Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Adrabetadex - National Institutes of Health/Mallinckrodt Pharmaceuticals

Drug Profile

Adrabetadex - National Institutes of Health/Mallinckrodt Pharmaceuticals

Alternative Names: 2-Hydroxypropyl-B-Cyclodextrin - Vtesse; 2-Hydroxypropyl-beta-cyclodextrin - Vtesse; HP-beta-CD - Vtesse; HPBCD - Vtesse; Hydroxypropyl betadex - Vtesse; Hydroxypropyl betadex intrathecal - Vtesse; Intrathecal hydroxypropyl betadex - Vtesse; IT-HPBCD - Vtesse; VTS 270

Latest Information Update: 01 Apr 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Institutes of Health (USA)
  • Developer Mallinckrodt plc; National Institute of Child Health and Human Development; Washington University School of Medicine
  • Class Antidementias; Beta-Cyclodextrins; Ethers
  • Mechanism of Action Binding agents; Cholesterol modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Niemann-Pick disease type C
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Niemann-Pick disease type C

Most Recent Events

  • 29 Mar 2019 Eunice Kennedy Shriver National Institute of Child Health and Human Development initiates enrolment in a phase I/II trial for Niemann-Pick Disease type C in USA (NCT03887533)
  • 27 Sep 2018 Vtesse plans a phase II trial for Niemann-Pick disease, type C in October 2018 , (NCT03687476)
  • 23 Aug 2018 Vtesse initiates enrolment in a clinical trial in Niemann-Pick disease type C (In children, In adolescents, In adults) in USA (NCT03643562)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top